Wearables
Closing the Gender Gap in Digital Health and Wearable Technologies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-07May 19, 2025
Neurodegenerative Disease Clinical Trials
Preparing for Growth in Neurodegenerative Treatment Opportunities: How Clinical Teams can Best Position Study Design and Strategy to Reach Study Participants
John Hamlet; Christine Martino, MPM; Sabine Krofczik-Wilhelm, Ph.D.; Alberto Lledó, M.D., Ph.D.
PPD clinical research business of Thermo Fisher Scientific
PAO-09-022-CL-09Sep 27, 2022
Decentralized Clinical Trials
A Breath of Fresh Air: How Decentralized Trial Options are Changing Respiratory Research
Tim Rich; Wesley Hicks, M.B.B.S., M.R.C.P., M.F.P.M.; Jenna McDonnell
PPD clinical research business of Thermo Fisher Scientific
PAO-10-21-CL-04Oct 12, 2021
Europe
Discussing Healthcare Across Europe
Moonbug Entertainment
PAO-04-22-R221-02Apr 07, 2021
Feature Story
Wearable Technology: Innovation, Adherence, and Clinical Outcomes
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q4-20-NI-002Dec 09, 2020
Feature Story
Wearable Technology: Targeting a Range of Uses and Indications
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q4-20-NI-003Dec 09, 2020
Feature Story
Wearable Technology: Their Future in Clinical Trials and the Real World
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q4-20-NI-004Dec 09, 2020
Wearables
First-ever: FDA Clears Biobeat's Wearable Watch and Patch for Non-invasive Cuffless Monitoring of Blood Pressure
Biobeat
PR-M08-19-NI-091Aug 30, 2019
Robotics
The Global Wearable Robotic Exoskeleton Market is Projected to Reach $5.4 Billion by 2028
BIS Research
PR-M01-19-NI-043Jan 15, 2019
Wearable
CES 2019: Omron Healthcare Launches First Wearable Blood Pressure Monitor, Previews Breakthrough Monitor with EKG and New Digital Health Services
Omron Healthcare
PR-M01-19-NI-027Jan 09, 2019
Innovation
Results of Landmark Wearable Defibrillator Trial to Be Presented as ACC.18 Late-Breaker
ZOLL Medical Corporation
PR-M03-18-NI-026Mar 07, 2018